Company Profile

Virax Biolabs is a Biotech and disruptive Medical Technology company focused on the prevention, detection and diagnosis of Viral threats. Our mission is the global provision of high-quality diagnostic kits, particularly T-Cell tests, which accurately and effectively predict an individual's immune response to significant viral threats. Our proprietary diagnostic T-cell technologies are virus agnostic, offering high levels of transparency, information and insight in a cost-efficient way. Key product ranges include ViraxClear, ViraxCare and flagship product being released 2022, Virax Immune.

Industry Classifications


In Vitro Diagnostics

In-Vitro Diagnostic Substance Manufacturing (325413)

In Vitro And In Vivo Diagnostic Substances (2835)

Contact Information

Investor Relations
Skyline Corporate Communications Group, LLC
Scott Powell
One Rockefeller Plaza
11th Floor
New York, NY 10020
M: 646-893-5835

Company Contact
Virax Biolabs Group Limited
30 Broadwick Street
London W1F 8JB
United Kingdom
T: +44 20 7788 7414